Xeris Biopharma Holdings, Inc.

XERS

XERSXeris Biopharma Holdings, Inc. US flag

NASDAQ Global Select

5.89

USD

-0.11

- -

1.02BMarket Cap

Income Statement (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	1	2	2	3	20	50	110	164	203	292
+ Sales & Services Revenue	1	2	2	3	20	50	110	164	203	292
- Cost of Revenue	- -	- -	- -	2	9	13	23	29	37	43
+ Cost of Goods & Services	- -	- -	- -	2	9	13	23	29	37	43
Gross Profit	1	2	2	1	11	36	88	135	166	249
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Operating Expenses	14	28	62	123	95	151	170	179	200	224
+ Selling, General & Admin	4	8	21	63	74	126	138	146	163	182
+ Research & Development	10	20	41	60	21	25	21	22	26	31
+ Other Operating Expense	- -	- -	- -	- -	- -	1	11	11	11	11
Operating Income (Loss)	-13	-27	-59	-122	-84	-115	-82	-44	-34	25
- Non-Operating (Income) Loss	- -	- -	1	4	8	8	14	19	23	24
+ Interest Expense, Net	- -	- -	1	4	8	7	12	22	25	24
+ Interest Expense	- -	- -	3	7	11	7	14	27	30	29
- Interest Income	- -	- -	2	3	3	- -	3	5	5	5
+ Other Non-Op (Income) Loss	- -	- -	- -	-1	- -	1	3	-2	-2	- -
Pretax Income	-13	-27	-60	-126	-91	-123	-96	-64	-57	1
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -	-1	-1	-2	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-13	-27	-60	-126	-91	-123	-95	-62	-55	1
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-13	-27	-60	-126	-91	-123	-95	-62	-55	1
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-13	-27	-60	-126	-91	-123	-95	-62	-55	1
- Preferred Dividends	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-13	-27	-60	-126	-91	-123	-95	-62	-55	1
EBIT	-13	-27	-59	-122	-84	-115	-82	-44	-34	25
EBITDA	-13	-26	-59	-121	-82	-113	-69	-31	-21	38
EBITDA Margin (%)	-1,220	-1,696.92	-2,435.99	-4,456.36	-401.66	-228.43	-62.83	-18.82	-10.35	12.88
EBITA	-13	-27	-59	-122	-84	-115	-82	-44	-34	25
Gross Margin (%)	99.26	99.74	100	41.11	54.35	73.14	79.47	82.52	81.86	85.41
Operating Margin (%)	-1,230.79	-1,711.38	-2,449.2	-4,495.96	-408.84	-232.22	-74.32	-26.85	-16.57	8.53
Profit Margin (%)	-1,228.74	-1,706.56	-2,479.57	-4,613.52	-446	-247.48	-85.86	-37.98	-27	0.19
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	1	1	2	13	13	13	13
Basic Weighted Avg Shares	2	2	12	26	43	79	136	138	147	160
Basic EPS, GAAP	-6.09	-12.24	-4.99	-4.81	-2.14	-1.55	-0.7	-0.45	-0.37	- -
Basic EPS from Cont Ops	-6.09	-12.24	-4.99	-4.81	-2.14	-1.55	-0.7	-0.45	-0.37	- -
Diluted Weighted Avg Shares	2	2	12	26	43	79	136	138	147	173
Diluted EPS, GAAP	-6.09	-12.24	-4.99	-4.81	-2.14	-1.55	-0.7	-0.45	-0.37	- -
Diluted EPS from Cont Ops	-6.09	-12.24	-4.99	-4.81	-2.14	-1.55	-0.7	-0.45	-0.37	- -

Balance Sheet (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	33	44	118	87	152	143	187	156	168	240
+ Cash, Cash Equivalents & STI	32	42	113	76	134	102	122	72	72	111
+ Cash & Cash Equivalents	32	42	46	20	38	67	122	67	72	111
+ ST Investments	- -	- -	67	56	96	35	- -	5	- -	- -
+ Accounts & Notes Receiv	- -	1	3	5	7	17	31	39	40	51
+ Accounts Receivable, Net	- -	1	- -	5	7	17	31	39	40	51
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	3	- -	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	2	8	18	25	39	48	69
+ Raw Materials	- -	- -	- -	1	3	5	7	17	32	38
+ Work In Process	- -	- -	- -	1	4	7	11	11	11	11
+ Finished Goods	- -	- -	- -	- -	1	5	6	10	5	19
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	1	1	2	5	3	5	9	6	7	10
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	1	2	22	7	162	158	166	155	143
+ Property, Plant & Equip, Net	- -	1	2	8	7	7	10	29	28	27
+ Property, Plant & Equip	1	1	3	9	9	11	15	35	35	35
- Accumulated Depreciation	- -	- -	1	1	3	4	6	6	7	8
+ LT Investments & Receivables	- -	- -	- -	13	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	13	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	- -	- -	155	148	137	127	116
+ Total Intangible Assets	- -	- -	- -	- -	- -	154	143	133	122	111
+ Goodwill	- -	- -	- -	- -	- -	23	23	23	23	23
+ Other Intangible Assets	- -	- -	- -	- -	- -	131	121	110	99	88
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -	- -	1	5	5	5	5
Total Assets	34	45	120	109	159	304	345	323	323	384
+ Payables & Accruals	1	3	5	18	17	53	45	40	40	55
+ Accounts Payable	1	2	1	6	3	9	5	12	2	3
+ Accrued Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	- -	1	4	13	14	44	40	29	37	52
+ ST Debt	- -	- -	- -	- -	- -	- -	2	3	21	6
+ ST Borrowings	- -	- -	- -	- -	- -	- -	- -	- -	15	- -
+ ST Finance Leases	- -	- -	- -	- -	- -	- -	2	3	6	6
+ Other ST Liabilities	1	2	5	9	11	26	27	51	40	48
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	1	2	5	9	11	26	27	51	40	48
Total Current Liabilities	3	5	10	27	28	79	74	95	100	110
+ LT Debt	- -	- -	32	58	87	88	196	226	250	252
+ LT Borrowings	- -	- -	32	58	87	88	187	191	217	220
+ LT Finance Leases	- -	- -	- -	- -	- -	- -	9	35	33	32
+ Other LT Liabilities	63	98	3	9	10	42	29	8	2	8
+ Accrued Liabilities	- -	- -	- -	7	7	12	4	2	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	63	98	3	2	4	30	26	6	2	8
Total Noncurrent Liabilities	63	98	34	67	97	130	226	234	252	260
Total Liabilities	65	103	45	95	125	209	299	329	353	370
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	2	3	196	261	371	555	600	610	642	685
+ Common Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	2	3	196	261	371	555	600	610	642	685
- Treasury Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-34	-61	-121	-246	-337	-460	-555	-617	-672	-671
+ Other Equity	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	-32	-58	75	14	34	95	45	-7	-30	14
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Equity	-32	-58	75	14	34	95	45	-7	-30	14
Total Liabilities & Equity	34	45	120	109	159	304	345	323	323	384
Shares Outstanding	19	19	21	27	60	125	136	138	149	166
Number of Employees	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -	- -	- -	11	38	39	38
Net Debt	-32	-42	-14	39	49	21	65	123	160	109
Net Debt to Equity	101.05	72.7	-18.34	268.68	146.39	21.84	144.09	-1,820.75	-541.91	798.4
Tangible Common Equity Ratio	-95.23	-128.52	62.82	13.25	21.21	-39.37	-48.88	-73.38	-75.22	-35.68
Current Ratio	13.13	9.06	11.59	3.2	5.4	1.8	2.54	1.64	1.67	2.19
Cash Conversion Cycle	- -	-149,999.4	- -	249.98	206.67	357.08	341.04	413.96	447.92	542.61

Cash Flow Statement (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	-13	-27	-60	-126	-91	-123	-95	-62	-55	1
+ Depreciation & Amortization	- -	- -	- -	1	1	2	13	13	13	13
+ Non-Cash Items	1	1	2	8	12	13	14	8	14	26
+ Stock-Based Compensation	1	- -	2	6	8	11	12	11	18	22
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	-1	-1	-2	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	- -	2	4	2	4	-1	-2	3
+ Chg in Non-Cash Work Cap	-4	1	2	12	-3	12	-35	-6	-9	-10
+ (Inc) Dec in Accts Receiv	- -	-1	-2	-5	-2	-6	-13	-8	-1	-11
+ (Inc) Dec in Inventories	- -	- -	- -	-2	-5	-7	-7	-15	-9	-19
+ (Inc) Dec in Prepaid Assets	- -	- -	-2	-1	1	3	-4	3	-2	-2
+ Inc (Dec) in Accts Payable	-3	2	5	15	- -	22	-14	6	-2	20
+ Inc (Dec) in Other	- -	- -	- -	5	4	- -	4	7	5	2
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-16	-25	-56	-104	-81	-96	-103	-47	-37	29
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	-1	-2	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	-1	-2	- -	- -	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	98	62	66	26	30	-1	-4	-2
+ Increase in Capital Stock	- -	- -	98	62	66	27	30	- -	- -	9
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	-1	- -	-1	-4	-11
+ Net Change in LT Investment	- -	- -	-67	-1	-27	61	35	-4	6	- -
+ Dec in LT Investment	- -	- -	2	101	75	104	35	40	40	- -
+ Inc in LT Investment	- -	- -	-69	-102	-102	-43	- -	-44	-34	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	38	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	38	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	-1	- -	-1	-1	-2	-1	-1
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	-1	-68	-2	-27	98	34	-6	5	-1
+ Dividends Paid	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	35	25	70	- -	102	- -	38	- -
+ Cash From Debt	- -	- -	35	60	95	- -	146	- -	50	- -
+ Repayments of Debt	- -	- -	- -	-35	-25	- -	-44	- -	-12	- -
+ Other Financing Activities	4	35	-5	-6	-10	1	-4	-1	2	13
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	4	35	128	81	126	27	127	-2	36	11
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	-12	10	4	-26	18	30	59	-55	4	39
EBITDA	-13	-26	-59	-121	-82	-113	-69	-31	-21	38
EBITDA Margin (%)	-1,220	-1,696.92	-2,435.99	-4,456.36	-401.66	-228.43	-62.83	-18.82	-10.35	12.88
Free Cash Flow	-16	-25	-58	-104	-81	-96	-103	-47	-37	29
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	-38	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	58
Free Cash Flow to Equity	- -	-25	-23	-79	-11	-96	-1	-47	1	29
Free Cash Flow per Basic Share	-7.43	-11.69	-4.8	-4	-1.89	-1.21	-0.76	-0.34	-0.25	0.18
Price/Free Cash Flow	- -	- -	-3.74	-1.76	-2.6	-2.42	-1.75	-6.88	-13.45	47.37
Cash Flow to Net Income	1.22	0.93	0.94	0.83	0.88	0.78	1.09	0.76	0.67	51.67
Capital Expenditures	- -	-1	-2	- -	- -	- -	- -	- -	- -	- -